Literature DB >> 21046863

"Take ten minutes": a dedicated ten minute medication review reduces polypharmacy in the elderly.

E K Walsh1, K Cussen.   

Abstract

Multiple and inappropriate medications are often the cause for poor health status in the elderly. Medication reviews can improve prescribing. This study aimed to determine if a ten minute medication review by a general practitioner could reduce polypharmacy and inappropriate prescribing in elderly patients. A prospective, randomised study was conducted. Patients over the age of 65 (n = 50) underwent a 10-minute medication review. Inappropriate medications, dosage errors, and discrepancies between prescribed versus actual medication being consumed were recorded. A questionnaire to assess satisfaction was completed following review. The mean number of medications taken by patients was reduced (p < 0.001). A medication was stopped in 35 (70%) patients. Inappropriate medications were detected in 27 (54%) patients and reduced (p < 0.001). Dose errors were detected in 16 (32%). A high level of patient satisfaction was reported. A ten minute medication review reduces polypharmacy, improves prescribing and is associated with high levels of patient satisfaction.

Entities:  

Mesh:

Year:  2010        PMID: 21046863

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  12 in total

Review 1.  Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use?

Authors:  Giuseppe Sergi; Marina De Rui; Silvia Sarti; Enzo Manzato
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

2.  Effect of nurse practitioner and pharmacist counseling on inappropriate medication use in family practice.

Authors:  John Fletcher; William Hogg; Barbara Farrell; Kirsten Woodend; Simone Dahrouge; Jacques Lemelin; William Dalziel
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

3.  Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults.

Authors:  Shervin Assari; Cheryl Wisseh; Mohammed Saqib; Hamid Helmi; Mohsen Bazargan
Journal:  Psych       Date:  2019-11-01

4.  Pharmacological management of co-morbid conditions at the end of life: is less more?

Authors:  S McLean; B Sheehy-Skeffington; N O'Leary; A O'Gorman
Journal:  Ir J Med Sci       Date:  2012-07-29       Impact factor: 1.568

5.  Evaluation of Multimedia Medication Reconciliation Software: A Randomized Controlled, Single-Blind Trial to Measure Diagnostic Accuracy for Discrepancy Detection.

Authors:  Blake J Lesselroth; Kathleen Adams; Victoria L Church; Stephanie Tallett; Yelizaveta Russ; Jack Wiedrick; Christopher Forsberg; David A Dorr
Journal:  Appl Clin Inform       Date:  2018-05-02       Impact factor: 2.342

6.  Social Determinants of Polypharmacy in First Generation Mexican Immigrants in the United States.

Authors:  Shervin Assari; Mohammed Saqib; Cheryl Wisseh; Mohsen Bazargan
Journal:  Int J Travel Med Glob Health       Date:  2019

Review 7.  Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.

Authors:  Alessandro Nobili; Silvio Garattini; Pier Mannuccio Mannucci
Journal:  J Comorb       Date:  2011-12-27

8.  Chronic Condition Clusters and Polypharmacy among Adults.

Authors:  Ami Vyas; Xiaoyun Pan; Usha Sambamoorthi
Journal:  Int J Family Med       Date:  2012-08-01

9.  Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.

Authors:  Christin Löffler; Eva Drewelow; Susanne D Paschka; Martina Frankenstein; Julia Eger; Lisa Jatsch; Emil C Reisinger; Johannes F Hallauer; Bernd Drewelow; Karen Heidorn; Helmut Schröder; Anja Wollny; Günther Kundt; Christian Schmidt; Attila Altiner
Journal:  Implement Sci       Date:  2014-10-06       Impact factor: 7.327

10.  Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.

Authors:  Diana Wucherer; Tilly Eichler; Johannes Hertel; Ingo Kilimann; Steffen Richter; Bernhard Michalowsky; Jochen René Thyrian; Stefan Teipel; Wolfgang Hoffmann
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.